coronavirus, Public Health

Update: EMA concludes that benefits of AstraZeneca vaccine outweigh the risks

EMA’s safety committee (PRAC) concludes that the benefits of the #COVID19Vaccine AstraZeneca still outweigh its risks despite possible link to rare blood clots associated with low levels of blood platelets. 👉Read more: https://t.co/WCdaKqOPxB pic.twitter.com/0NO8kh5a48 — EU Medicines Agency (@EMA_News) March 18, 2021 The EMA safety committee held a meeting on 18th March and found that:… Continue reading Update: EMA concludes that benefits of AstraZeneca vaccine outweigh the risks

coronavirus, Public Health

AstraZeneca vaccine suspended in Europe due to safety concerns

Several countries across Europe have suspended the AstraZeneca vaccine due to safety concerns. There have been reports of blood clotting and deaths in people who have been administered the vaccine. In comparison, there seems to be little trouble with the rollout of the vaccine in the UK with scientists there insisting that the jab is… Continue reading AstraZeneca vaccine suspended in Europe due to safety concerns